PATENT CLAIM ANALYSIS

Application Number: 15579926
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-08
Patent Classification: ["514", "002400"]

Abstract:
Antimicrobial peptides, compositions and methods are described that are useful for treating infectious diseases, including those caused by drug resistant Gram-negative bacteria (e.g.,  Pseudomonas  and  Acinetobacter ) and parasite-caused diseases such as malaria. The peptides include a modular kinocidin gamma-core connected directly, or through a short spacer, to a kinocidin C-terminal alpha-helix.

Claim (Index 14):
The isolated peptide of  claim 1 , wherein the peptide has antimicrobial activity.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 95.0
- Lexical Diversity: 1.2766
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10277233', '14357084', '14372629', '12294000', '11721915']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7451249171645843
- 35 USC 102 Novelty (BERT): 0.4981994038318861
- Combined Prediction Score: 0.7204323658313144
- Mean Citation Score: 245.63216
- Max Citation Score: 249.07849
- Similarity Product: 207.1781393467617

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test